International Journal of Cancer: Vol 127, No 9

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Journal Metrics

Tools

Submit an article

International Journal of Cancer

Journal list menu

Tools

Follow journal

International Journal of Cancer: Volume 127, Issue 9

Download PDFs

Spotlight

Spotlight

Mini Reviews

Epigenetic regulation of cancer growth by histone demethylases

Carcinogenesis

Kindlin-2 is expressed in malignant mesothelioma and is required for tumor cell adhesion and migration

Exogenous luminal nitric oxide exposure accelerates columnar transformation of rat esophagus

Cancer Cell Biology

CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide

Expression of laminin γ2 chain monomer enhances invasive growth of human carcinoma cells in vivo

Elevated expression of tumor necrosis factor-α signaling molecules in colonic tumors of Zucker obese (fa/fa) rats

Intraepithelial p63-dependent expression of distinct components of cell adhesion complexes in normal esophageal mucosa and squamous cell carcinoma

Glioblastoma cells incorporate into tumor vasculature and contribute to vascular radioresistance

Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells

Cancer Genetics

Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma

Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers

MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma

Tumor Immunology

The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity

In vivo tumor suppression activity by T cell-specific T-bet restoration†

Early Detection and Diagnosis

Plasma decorin predicts the presence of esophageal squamous cell carcinoma

Epidemiology

The health and economic effects of HPV DNA screening in The Netherlands†

Serum levels of vitamin D, PTH and calcium and breast cancer risk—a prospective nested case–control study

Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers

Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population

Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: Rapid incidence increase among young Danish women†‡

Cancer Therapy

Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance†

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial†‡

Short Reports

Investigation of a plasmid containing a novel immunotoxin VEGF165-PE38 gene for antiangiogenic therapy in a malignant glioma model

Pak1 and Pak2 are activated in recurrent respiratory papillomas, contributing to one pathway of Rac1-mediated COX-2 expression

Sign up for email alerts

Tools

More from this journal

In vivo tumor suppression activity by T cell-specific T-bet restoration ^†

The health and economic effects of HPV DNA screening in The Netherlands ^†

Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: Rapid incidence increase among young Danish women ^†^‡

Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance ^†

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial ^†^‡